List of Tables
Table 1. Global Alzheimer’s Disease Biomarker Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Alzheimer’s Disease Biomarker Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Alzheimer’s Disease Biomarker Market Competitive Situation by Manufacturers in 2024
Table 4. Global Alzheimer’s Disease Biomarker Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Alzheimer’s Disease Biomarker Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Alzheimer’s Disease Biomarker Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Alzheimer’s Disease Biomarker Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Alzheimer’s Disease Biomarker Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Alzheimer’s Disease Biomarker, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Alzheimer’s Disease Biomarker, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alzheimer’s Disease Biomarker, Product Type & Application
Table 12. Global Key Manufacturers of Alzheimer’s Disease Biomarker, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alzheimer’s Disease Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Biomarker as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alzheimer’s Disease Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Alzheimer’s Disease Biomarker Sales by Region (2020-2025) & (K Units)
Table 18. Global Alzheimer’s Disease Biomarker Sales Market Share by Region (2020-2025)
Table 19. Global Alzheimer’s Disease Biomarker Sales by Region (2026-2031) & (K Units)
Table 20. Global Alzheimer’s Disease Biomarker Sales Market Share by Region (2026-2031)
Table 21. Global Alzheimer’s Disease Biomarker Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Alzheimer’s Disease Biomarker Revenue Market Share by Region (2020-2025)
Table 23. Global Alzheimer’s Disease Biomarker Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Alzheimer’s Disease Biomarker Revenue Market Share by Region (2026-2031)
Table 25. North America Alzheimer’s Disease Biomarker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Alzheimer’s Disease Biomarker Sales by Country (2020-2025) & (K Units)
Table 27. North America Alzheimer’s Disease Biomarker Sales by Country (2026-2031) & (K Units)
Table 28. North America Alzheimer’s Disease Biomarker Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Alzheimer’s Disease Biomarker Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Alzheimer’s Disease Biomarker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Alzheimer’s Disease Biomarker Sales by Country (2020-2025) & (K Units)
Table 32. Europe Alzheimer’s Disease Biomarker Sales by Country (2026-2031) & (K Units)
Table 33. Europe Alzheimer’s Disease Biomarker Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Alzheimer’s Disease Biomarker Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Alzheimer’s Disease Biomarker Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Alzheimer’s Disease Biomarker Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Alzheimer’s Disease Biomarker Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Alzheimer’s Disease Biomarker Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Alzheimer’s Disease Biomarker Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Alzheimer’s Disease Biomarker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Alzheimer’s Disease Biomarker Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Alzheimer’s Disease Biomarker Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Alzheimer’s Disease Biomarker Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzheimer’s Disease Biomarker Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Alzheimer’s Disease Biomarker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Alzheimer’s Disease Biomarker Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Alzheimer’s Disease Biomarker Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Alzheimer’s Disease Biomarker Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Alzheimer’s Disease Biomarker Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Alzheimer’s Disease Biomarker Sales (K Units) by Type (2020-2025)
Table 51. Global Alzheimer’s Disease Biomarker Sales (K Units) by Type (2026-2031)
Table 52. Global Alzheimer’s Disease Biomarker Sales Market Share by Type (2020-2025)
Table 53. Global Alzheimer’s Disease Biomarker Sales Market Share by Type (2026-2031)
Table 54. Global Alzheimer’s Disease Biomarker Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Alzheimer’s Disease Biomarker Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Alzheimer’s Disease Biomarker Revenue Market Share by Type (2020-2025)
Table 57. Global Alzheimer’s Disease Biomarker Revenue Market Share by Type (2026-2031)
Table 58. Global Alzheimer’s Disease Biomarker Price (US$/Unit) by Type (2020-2025)
Table 59. Global Alzheimer’s Disease Biomarker Price (US$/Unit) by Type (2026-2031)
Table 60. Global Alzheimer’s Disease Biomarker Sales (K Units) by Application (2020-2025)
Table 61. Global Alzheimer’s Disease Biomarker Sales (K Units) by Application (2026-2031)
Table 62. Global Alzheimer’s Disease Biomarker Sales Market Share by Application (2020-2025)
Table 63. Global Alzheimer’s Disease Biomarker Sales Market Share by Application (2026-2031)
Table 64. Global Alzheimer’s Disease Biomarker Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Alzheimer’s Disease Biomarker Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Alzheimer’s Disease Biomarker Revenue Market Share by Application (2020-2025)
Table 67. Global Alzheimer’s Disease Biomarker Revenue Market Share by Application (2026-2031)
Table 68. Global Alzheimer’s Disease Biomarker Price (US$/Unit) by Application (2020-2025)
Table 69. Global Alzheimer’s Disease Biomarker Price (US$/Unit) by Application (2026-2031)
Table 70. Enzo Life Sciences Company Information
Table 71. Enzo Life Sciences Description and Business Overview
Table 72. Enzo Life Sciences Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Enzo Life Sciences Alzheimer’s Disease Biomarker Product
Table 74. Enzo Life Sciences Recent Developments/Updates
Table 75. Thermo Fisher Scientific Company Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Thermo Fisher Scientific Alzheimer’s Disease Biomarker Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. AnaSpec Company Information
Table 81. AnaSpec Description and Business Overview
Table 82. AnaSpec Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. AnaSpec Alzheimer’s Disease Biomarker Product
Table 84. AnaSpec Recent Developments/Updates
Table 85. Merck KGaA Company Information
Table 86. Merck KGaA Description and Business Overview
Table 87. Merck KGaA Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Merck KGaA Alzheimer’s Disease Biomarker Product
Table 89. Merck KGaA Recent Developments/Updates
Table 90. Cell Signaling Technology Company Information
Table 91. Cell Signaling Technology Description and Business Overview
Table 92. Cell Signaling Technology Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Cell Signaling Technology Alzheimer’s Disease Biomarker Product
Table 94. Cell Signaling Technology Recent Developments/Updates
Table 95. Fujirebio Company Information
Table 96. Fujirebio Description and Business Overview
Table 97. Fujirebio Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Fujirebio Alzheimer’s Disease Biomarker Product
Table 99. Fujirebio Recent Developments/Updates
Table 100. Imagilys Company Information
Table 101. Imagilys Description and Business Overview
Table 102. Imagilys Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Imagilys Alzheimer’s Disease Biomarker Product
Table 104. Imagilys Recent Developments/Updates
Table 105. NanoSomiX Company Information
Table 106. NanoSomiX Description and Business Overview
Table 107. NanoSomiX Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. NanoSomiX Alzheimer’s Disease Biomarker Product
Table 109. NanoSomiX Recent Developments/Updates
Table 110. QIAGEN Company Information
Table 111. QIAGEN Description and Business Overview
Table 112. QIAGEN Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. QIAGEN Alzheimer’s Disease Biomarker Product
Table 114. QIAGEN Recent Developments/Updates
Table 115. 23andMe Company Information
Table 116. 23andMe Description and Business Overview
Table 117. 23andMe Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. 23andMe Alzheimer’s Disease Biomarker Product
Table 119. 23andMe Recent Developments/Updates
Table 120. Quanterix Company Information
Table 121. Quanterix Description and Business Overview
Table 122. Quanterix Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Quanterix Alzheimer’s Disease Biomarker Product
Table 124. Quanterix Recent Developments/Updates
Table 125. C₂N Diagnostics Company Information
Table 126. C₂N Diagnostics Description and Business Overview
Table 127. C₂N Diagnostics Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. C₂N Diagnostics Alzheimer’s Disease Biomarker Product
Table 129. C₂N Diagnostics Recent Developments/Updates
Table 130. Quest Diagnostics Company Information
Table 131. Quest Diagnostics Description and Business Overview
Table 132. Quest Diagnostics Alzheimer’s Disease Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Quest Diagnostics Alzheimer’s Disease Biomarker Product
Table 134. Quest Diagnostics Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Alzheimer’s Disease Biomarker Distributors List
Table 138. Alzheimer’s Disease Biomarker Customers List
Table 139. Alzheimer’s Disease Biomarker Market Trends
Table 140. Alzheimer’s Disease Biomarker Market Drivers
Table 141. Alzheimer’s Disease Biomarker Market Challenges
Table 142. Alzheimer’s Disease Biomarker Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Alzheimer’s Disease Biomarker
Figure 2. Global Alzheimer’s Disease Biomarker Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer’s Disease Biomarker Market Share by Type: 2024 & 2031
Figure 4. Molecular Diagnostics Product Picture
Figure 5. Immunoassays Product Picture
Figure 6. Global Alzheimer’s Disease Biomarker Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Alzheimer’s Disease Biomarker Market Share by Application: 2024 & 2031
Figure 8. Hospitals and Clinics
Figure 9. Diagnostic Laboratories
Figure 10. Others
Figure 11. Global Alzheimer’s Disease Biomarker Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Alzheimer’s Disease Biomarker Market Size (2020-2031) & (US$ Million)
Figure 13. Global Alzheimer’s Disease Biomarker Sales (2020-2031) & (K Units)
Figure 14. Global Alzheimer’s Disease Biomarker Average Price (US$/Unit) & (2020-2031)
Figure 15. Alzheimer’s Disease Biomarker Report Years Considered
Figure 16. Alzheimer’s Disease Biomarker Sales Share by Manufacturers in 2024
Figure 17. Global Alzheimer’s Disease Biomarker Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Alzheimer’s Disease Biomarker Players: Market Share by Revenue in Alzheimer’s Disease Biomarker in 2024
Figure 19. Alzheimer’s Disease Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Alzheimer’s Disease Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Alzheimer’s Disease Biomarker Sales Market Share by Country (2020-2031)
Figure 22. North America Alzheimer’s Disease Biomarker Revenue Market Share by Country (2020-2031)
Figure 23. United States Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Alzheimer’s Disease Biomarker Sales Market Share by Country (2020-2031)
Figure 26. Europe Alzheimer’s Disease Biomarker Revenue Market Share by Country (2020-2031)
Figure 27. Germany Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Alzheimer’s Disease Biomarker Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Alzheimer’s Disease Biomarker Revenue Market Share by Region (2020-2031)
Figure 34. China Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Alzheimer’s Disease Biomarker Sales Market Share by Country (2020-2031)
Figure 42. Latin America Alzheimer’s Disease Biomarker Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Alzheimer’s Disease Biomarker Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Alzheimer’s Disease Biomarker Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Alzheimer’s Disease Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Alzheimer’s Disease Biomarker by Type (2020-2031)
Figure 52. Global Revenue Market Share of Alzheimer’s Disease Biomarker by Type (2020-2031)
Figure 53. Global Alzheimer’s Disease Biomarker Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Alzheimer’s Disease Biomarker by Application (2020-2031)
Figure 55. Global Revenue Market Share of Alzheimer’s Disease Biomarker by Application (2020-2031)
Figure 56. Global Alzheimer’s Disease Biomarker Price (US$/Unit) by Application (2020-2031)
Figure 57. Alzheimer’s Disease Biomarker Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
